| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| ||||||||||||||||||||||||||||||||
1 Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.
2 Institute of Gerontology and Geriatrics, University of Perugia, Italy.
3 Department of Clinical and Experimental Medicine, Section of Internal Medicine and Geriatrics, University of Ferrara, Italy.
4 Division of Nutritional Sciences, Cornell University, Ithaca, New York.
5 Division of Geriatric Medicine and Gerontology, Johns Hopkins University, Baltimore, Maryland.
6 Geriatric Rehabilitation Unit, Azienda Sanitaria di Firenze, Italy.
7 Tuscany Region Health Agency, Firenze, Italy.
8 Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, National Institutes of Health, Bethesda, Maryland.
Address correspondence to Luigi Ferrucci, MD, PhD, National Institute on Aging, NIA, Harbor Hospital, 5th Floor, 3001 S. Hanover St., Baltimore, MD 21225. E-mail: ferruccilu{at}grc.nia.nih.gov
Background. The primary biologic mechanism that causes frailty in older persons has never been adequately explained. According to recent views, oxidative stress may be the driving force of this condition. We tested the hypothesis that, independent of confounders, low plasma levels of vitamin E (
-tocopherol), the main fat-soluble human antioxidant, are associated with the frailty syndrome in older persons free from dementia and disability.
Methods. The study sample included 827 older (
65 years) persons (women, 54%) who participated in a population-based epidemiological study. Frail participants were identified based on the presence of at least three of five of the following features: self-reported weight loss, low energy, slow gait speed, low grip strength, and low physical activity. Participants with none of these features were considered nonfrail, while participants with one or two were considered intermediate frail. Plasma vitamin E levels were determined using reverse-phase high-performance liquid chromatography. Measured confounders included lower extremity muscle strength, cognitive function, diseases, and factors related to vitamin E metabolism.
Results. Age- and gender-adjusted levels of vitamin E decreased gradually from the nonfrail to the frail group (p for trend =.015). In the logistic model adjusted for multiple potential confounders, participants in the highest vitamin E tertile were less likely to be frail than were participants in the lowest vitamin E tertile (odds ratio, 0.30; 95% confidence interval, 0.10–0.91).
Conclusions. Our findings show an association between low circulating levels of one of the most important components of the human antioxidant system and the presence of frailty.
This article has been cited by other articles:
 |
|
 |
|
  M. Shardell, G. E. Hicks, R. R. Miller, S. Kritchevsky, D. Andersen, S. Bandinelli, A. Cherubini, and L. Ferrucci Association of Low Vitamin D Levels With the Frailty Syndrome in Men and Women J Gerontol A Biol Sci Med Sci, January 20, 2009; (2009) gln007v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bartali, E. A. Frongillo, J. M. Guralnik, M. H. Stipanuk, H. G. Allore, A. Cherubini, S. Bandinelli, L. Ferrucci, and T. M. Gill Serum Micronutrient Concentrations and Decline in Physical Function Among Older Persons JAMA, January 23, 2008; 299(3): 308 - 315. [Abstract] [Full Text] [PDF]
|
|
| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
